APR 20, 2019 08:41 PM PDT

Underwater Forest May Bring New Therapeutics

WRITTEN BY: Nouran Amin

Microbes that produce defensive compounds have contributed to the major source of antibiotics and other therapeutics. However, due to the rise of antibiotic-resistant bacteria, researchers are now seeking new drug candidates offshore.

Currently, a family of sea-dwelling bacteria known as Actinobacteria have helped in producing new antibiotics with their rich source of bioactive microbial compounds. Now a study published in Frontiers in Microbiology, revealed that an underwater species of seaweed, called Laminaria ochroleuca, serves as a rich source of bacteria with antimicrobial and anticancer compounds--the discovery can lead to new therapeutics.

"About half of the 20,000+ microbe-derived drug candidates currently known come from Actinobacteria," says senior study author Dr. Maria de Fátima Carvalho of the Interdisciplinary Center of Marine and Environmental Research (CIIMAR), Portugal. "Now the supply of new species on land -- where they form spores and branched networks just like a fungus -- is beginning to run out. Several novel drug leads derived from marine Actinobacteria are already known. These include anticancer agent salinosporamide A, currently in clinical trials, and several new antibiotics that are effective against drug-resistant infections like MRSA and tuberculosis."

The study showed that extracts of the seaweed L. ochroleuca is a rich source of Actinobacteria with promising antimicrobial and anticancer activities.

"The brown alga Laminaria ochroleuca forms complex structures called kelp forests, which are among the most diverse and productive ecosystems in the world," says Carvalho. "But until now, no-one had characterized the Actinobacteria that live inside L. ochroleuca. Seven of the extracts inhibited growth of breast and particularly nerve cell cancers, while having no effect on non-cancer cells."

Kelp forests are among the most diverse and productive ecosystems in the world. Image: Shutterstock.

"We identified extracts from two Actinobacteria strains that do not match any known compounds in the most comprehensive international database of natural bioactive compounds. We intend to follow up on these exciting results."

Source: Frontiers

About the Author
  • Nouran enjoys writing on various topics including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
DEC 05, 2019
Technology
DEC 05, 2019
Biomagents for Drug Discovery
Scientists have recently developed a chip-like device that utilizes tiny magnets that sort large populations of mixed cell types. "We casually agreed...
DEC 05, 2019
Drug Discovery & Development
DEC 05, 2019
Effective Vaccines for Lyme Disease?
Currently, there are no effective vaccines available for the presentation of Lyme disease. The only preventive efforts present includes “guiding&rdqu...
DEC 05, 2019
Drug Discovery & Development
DEC 05, 2019
Gene Variant Could Be a Therapeutic Target For Alzheimer Disease
A variation in genetics for an individual at high-risk for Alzheimer development has defied the odds for being dementia-free way beyond anticipated. The in...
DEC 05, 2019
Technology
DEC 05, 2019
How artificial intelligence (AI) is improving immunotherapy
Researchers at Case Western Reserve University’s digital imaging lab are pioneering the use of Artificial Intelligence (AI) to predict the efficacy o...
DEC 05, 2019
Drug Discovery & Development
DEC 05, 2019
Vaccine Causes More Polio Cases than Wild Virus
The World Health Organization (WHO) has confirmed that 11 new cases of polio in five African countries including Nigeria, Congo and Angola were caused by a...
DEC 05, 2019
Neuroscience
DEC 05, 2019
Single Dose Ketamine Could Rewire Alcohol, Drug Dependance
Presentation by Tobias Stephenson about previous research exploring ketamine as an addiction treatment.    Researchers at University College Lond...
Loading Comments...